Answer
Yes, venous blood clots have been reported in patients taking palbociclib (Ibrance), and patients should be monitored for signs and symptoms of deep vein thrombosis and pulmonary embolism and treated as medically appropriate.
Sources for this answer
- IBRANCE 75 mg film-coated tabletsPfizer Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 10Document updated
Sources checked